27/05/2024  08:00:42 Var. 0.000 Volume Denaro08:25:03 Lettera08:25:03 Capitalizzazione di mercato Dividend Y. Rapporto P/E
322.300EUR 0.00% -
Fatturato: -
320.300Quantità in denaro: 31 323.300Quantità in lettera: 31 38.82 bill.EUR - -

Descrizione business

Humana Inc., headquartered in Louisville, Ky., is a leading health and well-being company focused on making it easy for people to achieve their best health with clinical excellence through coordinated care. The company’s strategy integrates care delivery, the member experience, and clinical and consumer insights to encourage engagement, behavior change, proactive clinical outreach and wellness for the millions of people we serve across the country.
 

Consiglio di amministrazione & Consiglio di sorveglianza

CEO
Bruce D. Broussard
Consiglio di amministrazione
Susan M. Diamond, Vishal Agrawal, M.D., Sam Deshpande, John-Paul Felter, William Fleming, PharmD, Tim Huval, George Renaudin II, Sanjay K. Shetty, M.D., Joseph C. Ventura
Consiglio di sorveglianza
Kurt J. Hilzinger, Raquel C. Bono, M.D., Bruce D. Broussard, Frank A. D'Amelio, David T. Feinberg, M.D., Wayne A.I. Frederick, M.D, John W. Garratt, Karen W. Katz, Marcy S. Klevorn, William J. McDonald, Jorge S. Mesquita, Brad D. Smith
 

Dati aziendali

Name: Humana Inc.
Indirizzo: 500 West Main Street,Louisville, Kentucky 40202, USA
Telefono: +1-502-580-1000
Fax: +1-502-580-4188
E-mail: CorporateSecretary@humana.com
Internet: www.humana.com
Industria: Financial
Settore: Insurance
Sub settore: -
Fine dell'anno finanziario: 31/12
Flottante libero: -
Data dell'IPO: -

Rapporti con gli investitori

Name: Lisa M. Stoner
IR telefono: +1-502-580-2652
IR Fax: +1-502-508-1210
IR e-mail: lstamper@humana.com

Company calendar

CW 31 | 31/07/2024 Interim Report 2nd Quarter/6 Months
CW 44 | 30/10/2024 Interim Report 3rd Quarter/9 Months
 

Principali azionisti

Altri
 
50.64%
Blackrock Inc.
 
9.03%
Vanguard Group, Inc.
 
9.01%
Price (T.Rowe) Associates Inc
 
6.14%
Wellington Management Group, LLP
 
5.88%
FMR, LLC
 
5.88%
State Street Corporation
 
4.57%
Capital International Investors
 
3.50%
GQG Partners LLC
 
1.80%
Altri
 
3.55%